The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study
Open accessAbstract
Extranodal NK/T-cell lymphoma, nasal type, is a rare and highly aggressive disease with a grim prognosis. No therapeutic strategy is currently identified in relapsing patients. We report the results of a French prospective phase II trial of an L-asparaginase-containing regimen in 19 patients with relapsed or refractory disease treated in 13 centers. Eleven patients were in relapse and 8 patients were refractory to their first line of treatment. L-Asparaginase–based treatment yielded objective responses in 14 of the 18 evaluable patients after 3 cycles. Eleven patients entered complete remission (61%), and only 4 of them relapsed. The median overall survival time was 1 year, with a median response duration of 12 months. The main adverse events were hepatitis, cytopenia, and allergy. The absence of antiasparaginase antibodies and the disappearance of Epstein-Barr virus serum DNA were significantly associated with a better outcome. These data confirm the excellent activity of L-asparaginase–containing regimens in extranodal NK/T-cell lymphoma. L-Asparaginase–based treatment should thus be considered for salvage therapy, especially in patients with disseminated disease. First-line L-asparaginase combination therapy for extranodal NK/T-cell lymphoma warrants evaluation in prospective trials. This trial is registered at www.clinicaltrials.gov as #NCT00283985.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues
Swerdlow, S. H. (2017) · Medical Entomology and Zoology · Cited by 12,933
Revised Response Criteria for Malignant Lymphoma
Cheson, B. D., Pfistner, B., Juweid, M. E., Gascoyne, R. D., Specht, L., Horning, S. J., Coiffier, B., Fisher, R. I., Hagenbeek, A., Zucca, E., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.2403 · Cited by 4,426
One-Sample Multiple Testing Procedure for Phase II Clinical Trials
Fleming, T. R. (1982) · Biometrics · doi:10.2307/2530297 · Cited by 1,003
Au, W.-Y., Weisenburger, D. D., Intragumtornchai, T., Nakamura, S., Kim, W.-S., Sng, I., Vose, J., Armitage, J. O., Liang, R., & for the International Peripheral T-Cell Lymphoma Project (2009) · Blood · doi:10.1182/blood-2008-10-185256 · Cited by 736
Kim, S. J., Kim, K., Kim, B. S., Kim, C. Y., Suh, C., Huh, J., Lee, S.-W., Kim, J. S., Cho, J., Lee, G.-W., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.8592 · Cited by 342
Au, W., Pang, A. W. K., Choy, C., Chim, C. S., & Kwong, Y. (2004) · Blood · doi:10.1182/blood-2003-12-4197 · Cited by 295
Selective apoptosis of natural killer‐cell tumours by l‐asparaginase
Ando, M., Sugimoto, K., Kitoh, T., Sasaki, M., Mukai, K., Ando, J., Egashira, M., Schuster, S. M., & Oshimi, K. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05694.x · Cited by 161
Progress in understanding and managing natural killer‐cell malignancies
Oshimi, K. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06835.x · Cited by 157
Kwong, Y., Anderson, B. O., Advani, R. H., Kim, W.-S., Levine, A. M., & Lim, S.-T. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70265-7 · Cited by 120
Zalewska‐Szewczyk, B., Andrzejewski, W., Mlynarski, W. M., Jędrychowska-Dańska, K., Witas, H. W., & Bodalski, J. (2007) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190701292049 · Cited by 88
Cited by
Amino Acids and Their Transporters in T Cell Immunity and Cancer Therapy
Wang, W., & Zou, W. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.09.006 · Cited by 298
Signaling pathways in cancer metabolism: mechanisms and therapeutic targets
You, M., Xie, Z., Zhang, N., Zhang, Y., Xiao, D., Liu, S., Zhuang, W., Li, L., & Tao, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01442-3 · Cited by 292
Do Bacteria Provide an Alternative to Cancer Treatment and What Role Does Lactic Acid Bacteria Play?
Dicks, L. M. T., & Vermeulen, W. (2022) · Microorganisms · doi:10.3390/microorganisms10091733 · Cited by 25
Metadata
- Authors
- Jaccard, A., Gachard, N., Marin, B., Rogez, S., Audrain, M., Suarez, F., Tilly, H., Morschhauser, F., Thieblemont, C., Ysebaert, L., Devidas, A., Petit, B., de Leval, L., Gaulard, P., Feuillard, J., Bordessoule, D., Hermine, O., & Intergroup, F. T. G. A. G.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2011-02-10
- Volume
- 117
- Issue
- 6
- Pages
- 1834-1839
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2071270987
- Cited by
- 381
- References
- 11
- FWCI
- 12.31
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study. https://app.cochat.ai/papers/10.1182/blood-2010-09-307454
- The paper
- Jaccard, A., Gachard, N., Marin, B., Rogez, S., Audrain, M., Suarez, F., Tilly, H., Morschhauser, F., Thieblemont, C., Ysebaert, L., Devidas, A., Petit, B., de Leval, L., Gaulard, P., Feuillard, J., Bordessoule, D., Hermine, O., & Intergroup, F. T. G. A. G. (2011). Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study. Blood. https://doi.org/10.1182/blood-2010-09-307454
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.